Moreover, AMG 330 resulted in significantly higher cytotoxicity in specimens from patients with newly diagnosed AML than those with relapsed/refractory disease despite similar levels of CD33 on myeloblasts (69). Here, CD33 is linked to acute myeloid leukemia.